Toward Disruption: Transparency in Clinical Trials
April 16, 2013 | Transparency Life Sciences (TLS) is calling for transparency in clinical trials to improve study design, quality and outcomes while drastically reducing costs. Their work is aligning with other industry trends as well. Xconomy
Click here to log in.
Text Only 2000 character limit
Page 1 of 1